These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

98 related articles for article (PubMed ID: 29279586)

  • 1. Expression of clusterin in colorectal carcinoma in relation to clinicopathological criteria.
    Gomaa W; Al-Ahwal M; Al-Maghrabi H; Buhmeida A; Al-Qahtani M; Al-Maghrabi B; Al-Maghrabi J
    Malays J Pathol; 2017 Dec; 39(3):243-250. PubMed ID: 29279586
    [TBL] [Abstract][Full Text] [Related]  

  • 2. c-MET immunostaining in colorectal carcinoma is associated with local disease recurrence.
    Al-Maghrabi J; Emam E; Gomaa W; Saggaf M; Buhmeida A; Al-Qahtani M; Al-Ahwal M
    BMC Cancer; 2015 Oct; 15():676. PubMed ID: 26459369
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Low expression of MUC2 is associated with longer disease-free survival in patients with colorectal carcinoma.
    Al-Maghrabi J; Sultana S; Gomaa W
    Saudi J Gastroenterol; 2019; 25(1):61-66. PubMed ID: 30226481
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Overexpression of PAK-1 is an independent predictor of disease recurrence in colorectal carcinoma.
    Al-Maghrabi J; Emam E; Gomaa W; Al-Qaydy D; Al-Maghrabi B; Buhmeida A; Abuzenadah A; Al-Qahtani M; Al-Ahwal M
    Int J Clin Exp Pathol; 2015; 8(12):15895-902. PubMed ID: 26884861
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Immunohistochemical staining of cytokeratin 20 and cytokeratin 7 in colorectal carcinomas: Four different immunostaining profiles.
    Al-Maghrabi J; Emam E; Gomaa W
    Saudi J Gastroenterol; 2018; 24(2):129-134. PubMed ID: 29637921
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Decreased immunoexpression of standard form of CD44 is an independent favourable predictor of nodal metastasis in colorectal carcinoma.
    Al-Maghrabi J; Gomaa W; Buhmeida A; Al-Qahtani M; Al-Ahwal M
    Anticancer Res; 2012 Aug; 32(8):3455-61. PubMed ID: 22843930
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Prognostic significance of VEGFR1/Flt-1 immunoexpression in colorectal carcinoma.
    Al-Maghrabi J; Gomaa W; Buhmeida A; Qari Y; Al-Qahtani M; Al-Ahwal M
    Tumour Biol; 2014 Sep; 35(9):9045-51. PubMed ID: 24908415
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Cytoplasmic Pin1 expression is correlated with poor prognosis in colorectal cancer.
    Pyo JS; Son BK; Oh IH
    Pathol Res Pract; 2018 Nov; 214(11):1848-1853. PubMed ID: 30244946
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Gremlin1 expression associates with serrated pathway and favourable prognosis in colorectal cancer.
    Pelli A; Väyrynen JP; Klintrup K; Mäkelä J; Mäkinen MJ; Tuomisto A; Karttunen TJ
    Histopathology; 2016 Nov; 69(5):831-838. PubMed ID: 27257976
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The significance of sonic hedgehog immunohistochemical expression in colorectal carcinoma.
    Al Ghamdi D; Gomaa W; Abulaban A; Al-Ahwal M; Buhmeida A; Al-Qahtani M; Al-Maghrabi J
    J Microsc Ultrastruct; 2015; 3(4):169-174. PubMed ID: 30023196
    [TBL] [Abstract][Full Text] [Related]  

  • 11. CYP24A1 is a potential biomarker for the progression and prognosis of human colorectal cancer.
    Sun H; Wang C; Hao M; Sun R; Wang Y; Liu T; Cong X; Liu Y
    Hum Pathol; 2016 Apr; 50():101-8. PubMed ID: 26997443
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Prognostic value of Osteopontin (SPP1) in colorectal carcinoma requires a personalized molecular approach.
    Assidi M; Gomaa W; Jafri M; Hanbazazh M; Al-Ahwal M; Pushparaj P; Al-Harbi A; Al-Qahtani M; Buhmeida A; Al-Maghrabi J
    Tumour Biol; 2019 Sep; 41(9):1010428319863627. PubMed ID: 31500540
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Comprehensive assessment of tumour budding by cytokeratin staining in colorectal cancer.
    Rieger G; Koelzer VH; Dawson HE; Berger MD; Hädrich M; Inderbitzin D; Lugli A; Zlobec I
    Histopathology; 2017 Jun; 70(7):1044-1051. PubMed ID: 28061021
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Keratin 7 expression in lymph node metastases but not in the primary tumour correlates with distant metastases and poor prognosis in colon carcinoma.
    Czapiewski P; Bobowicz M; Pęksa R; Skrzypski M; Gorczyński A; Szczepańska-Michalska K; Korwat A; Jankowski M; Zegarski W; Szulgo-Paczkowska A; Polec T; Piątek M; Skokowski J; Haybaeck J; Żaczek A; Biernat W
    Pol J Pathol; 2016; 67(3):228-234. PubMed ID: 28155971
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Evaluation of the correlation of KAI1/CD82, CD44, MMP7 and β-catenin in the prediction of prognosis and metastasis in colorectal carcinoma.
    Wu Q; Yang Y; Wu S; Li W; Zhang N; Dong X; Ou Y
    Diagn Pathol; 2015 Sep; 10():176. PubMed ID: 26408312
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Clusterin expression is associated with decreased disease-free survival of patients with colorectal carcinomas.
    Redondo M; Rodrigo I; Alcaide J; Tellez T; Roldan MJ; Funez R; Diaz-Martin A; Rueda A; Jiménez E
    Histopathology; 2010 Jun; 56(7):932-6. PubMed ID: 20497247
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Increased expression of CD133 is a strong predictor of poor outcome in stage I colorectal cancer patients.
    Reggiani Bonetti L; Migaldi M; Caredda E; Boninsegna A; Ponz De Leon M; Di Gregorio C; Barresi V; Scannone D; Danese S; Cittadini A; Sgambato A
    Scand J Gastroenterol; 2012 Oct; 47(10):1211-7. PubMed ID: 22856425
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Down-regulation of the microRNA processing enzyme Dicer is a prognostic factor in human colorectal cancer.
    Faggad A; Kasajima A; Weichert W; Stenzinger A; Elwali NE; Dietel M; Denkert C
    Histopathology; 2012 Oct; 61(4):552-61. PubMed ID: 22716222
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Oncogenic role of clusterin overexpression in multistage colorectal tumorigenesis and progression.
    Xie D; Sham JS; Zeng WF; Che LH; Zhang M; Wu HX; Lin HL; Wen JM; Lau SH; Hu L; Guan XY
    World J Gastroenterol; 2005 Jun; 11(21):3285-9. PubMed ID: 15929184
    [TBL] [Abstract][Full Text] [Related]  

  • 20. High expression of Y-box-binding protein 1 is associated with local recurrence and predicts poor outcome in patients with colorectal cancer.
    Yan X; Yan L; Zhou J; Liu S; Shan Z; Jiang C; Tian Y; Jin Z
    Int J Clin Exp Pathol; 2014; 7(12):8715-23. PubMed ID: 25674237
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.